FDA & Psychedelics: Emyria has been selected for a limited in-person speaking slot at a US FDA public hearing on “Considerations for Potential Future Therapeutic Use of Psychedelic Drugs,” with focus on provider training, patient safety, access, and standardised clinical data. Public Health—Measles: Bangladesh’s measles outbreak has hit more than 1.89 lakh cases and over 1,000 deaths, with experts pointing to routine immunisation disruption after COVID. US Outbreak Update: Pennsylvania reports a third measles-associated death this year, with hundreds of confirmed cases and very low vaccination coverage among confirmed patients. Healthcare Access & Workforce: Malaysia’s Medical Association president says retaining public-sector doctors will be the top priority, stressing career progression, working conditions, and safer remote-service support. Affordability Pressure: Australia’s health department flags rapidly rising specialist out-of-pocket costs and targets “excessive” fees. Cybersecurity: A Colombia report says 6 in 10 cyberattacks target hospitals and clinics, risking care disruption and sensitive medical data. Care Delivery & Tech: Frazier Healthcare Partners names Jonathan Lujan CEO of MatrixCare after its acquisition from Resmed, aiming to strengthen post-acute EHR and revenue cycle tools. Local Health Infrastructure: Sarawak’s MOH says rural care will continue after a temporary Flying Doctor Service suspension, using land and water transport with risk checks.